DM
TIL icon

Deerfield Management’s Instil Bio TIL Stock Holding History

Deerfield Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-55,787
Closed -$19.9M – 141
2021
Q3 		$19.9M Hold
55,787
– – 0.39% 68
2021
Q2 		$21.6M Hold
55,787
– – 0.38% 80
2021
Q1 		$28M Buy
+55,787
New +$28.6M 0.59% 58

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Deerfield Management's TIL Position: Q4 2021 in Review

Deerfield Management sold out of Instil Bio (TIL) in Q4 2021, closing a stake of 55,787 shares — an estimated $19.9M sold.

Deerfield Management first reported a position in TIL in Q1 2021 and held it in 3 quarters. The position peaked at $28M in Q1 2021. 77 funds tracked by Wall St. Rank hold TIL as of Q4 2021.

  • Deerfield Management reported no remaining Instil Bio position as of Q4 2021 after selling out during the quarter.
  • Deerfield Management sold 55,787 Instil Bio shares in Q4 2021, an estimated $19.9M.
  • Deerfield Management first reported a position in Instil Bio in Q1 2021 and held it in 3 quarters.
  • Deerfield Management's Instil Bio position peaked at $28M in Q1 2021.
  • 77 funds tracked by Wall St. Rank held Instil Bio as of Q4 2021.

Based on Deerfield Management's 13F filing for Q4 2021, filed 14 Feb 2022.